loadpatents
name:-0.005403995513916
name:-0.0020451545715332
name:-0.0004730224609375
Waldron; Alpana Patent Filings

Waldron; Alpana

Patent Applications and Registrations

Patent applications and USPTO patent grants for Waldron; Alpana.The latest application filed is for "association of biomarkers with patient outcome".

Company Profile
0.1.3
  • Waldron; Alpana - Fairfield CT US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Correlation of molecular markers with clinical outcome in GBM patients radiation treated with or without gefitinib
Grant 8,557,527 - Chakravarti , et al. October 15, 2
2013-10-15
Association Of Biomarkers With Patient Outcome
App 20120270233 - Waldron; Donald E. ;   et al.
2012-10-25
Correlation Of Molecular Markers With Clinical Outcome In Gbm Patients Radiation Treated With Or Without Gefitinib
App 20100144540 - Chakravarti; Arnab ;   et al.
2010-06-10
Src Activation For Determining Cancer Prognosis And As A Target For Cancer Therapy
App 20100081666 - COUGHLIN; Christina M. ;   et al.
2010-04-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed